Mark T. Iwicki - Mar 25, 2024 Form 3 Insider Report for Homology Medicines, Inc. (QTTB)

Role
Director
Signature
/s/ Eric Bell, Attorney-in-Fact
Stock symbol
QTTB
Transactions as of
Mar 25, 2024
Transactions value $
$0
Form type
3
Date filed
3/27/2024, 05:16 PM
Previous filing
Jan 5, 2024
Next filing
May 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding QTTB Stock Option (Right to Buy) Mar 25, 2024 Common Stock 37.2K $7.29 Direct F1
holding QTTB Stock Option (Right to Buy) Mar 25, 2024 Common Stock 7.62K $7.29 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option vested and became exercisable on January 4, 2022, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
F2 25% of the shares underlying this option vested and became exercisable on December 17, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney